Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

IM Cannabis (IMCC) Cost of Revenue: 2019-2025

Historic Cost of Revenue for IM Cannabis (IMCC) over the last 6 years, with Sep 2025 value amounting to $8.1 million.

  • IM Cannabis' Cost of Revenue rose 2.65% to $8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.7 million, marking a year-over-year decrease of 12.22%. This contributed to the annual value of $33.3 million for FY2024, which is 18.29% up from last year.
  • IM Cannabis' Cost of Revenue amounted to $8.1 million in Q3 2025, which was up 20.73% from $6.7 million recorded in Q2 2025.
  • In the past 5 years, IM Cannabis' Cost of Revenue ranged from a high of $10.2 million in Q2 2024 and a low of $3.3 million during Q1 2021.
  • For the 3-year period, IM Cannabis' Cost of Revenue averaged around $7.5 million, with its median value being $7.2 million (2023).
  • In the last 5 years, IM Cannabis' Cost of Revenue surged by 584.49% in 2021 and then plummeted by 34.19% in 2025.
  • IM Cannabis' Cost of Revenue (Quarterly) stood at $7.0 million in 2021, then increased by 22.70% to $8.6 million in 2022, then declined by 18.13% to $7.0 million in 2023, then rose by 8.36% to $7.6 million in 2024, then climbed by 2.65% to $8.1 million in 2025.
  • Its last three reported values are $8.1 million in Q3 2025, $6.7 million for Q2 2025, and $6.3 million during Q1 2025.